Presentation TCT 2012 Why Clinical Research in Mitral Valve Disease Has Been Challenging: Rationale for MVARC Presenter: David Adams October 25, 2012 REGISTER for free or LOG IN to view this content Mitral Valve Presentation TCT 2012 Up Next Presentation TCT 2012 STOP-IC: A Prospective, Randomized Trial of Cilostazol after Endovascular Treatment of Femoropopliteal Lesions Presenter: Hiroyoshi Yokoi October 22, 2012 More slides + Presentation TCT 2012 Preclinical Review: Experimental Considerations and Challenges for TAVR Validation Presenter: Stanton Rowe October 23, 2012 Presentation TCT 2012 A View to Future Trials: HORIZONS-AMI II and Others Presenter: Roxana Mehran October 24, 2012 We Recommend
Presentation TCT 2012 STOP-IC: A Prospective, Randomized Trial of Cilostazol after Endovascular Treatment of Femoropopliteal Lesions Presenter: Hiroyoshi Yokoi October 22, 2012
Presentation TCT 2012 Preclinical Review: Experimental Considerations and Challenges for TAVR Validation Presenter: Stanton Rowe October 23, 2012
Presentation TCT 2012 A View to Future Trials: HORIZONS-AMI II and Others Presenter: Roxana Mehran October 24, 2012